Recommendations for Specimen and Therapy Selection in Colorectal Cancer

Area of Science:

• Oncology
• Genomics
• Cancer Research

Background:

• Next-generation sequencing (NGS) is crucial for identifying actionable mutations in advanced colorectal cancer (CRC) for targeted therapies.
• Clinical guidelines conflict on whether to sequence primary tumors or metastases, or both.

Purpose of the Study:

• To resolve the conflict regarding optimal tumor site selection for sequencing in advanced colorectal cancer.
• To provide evidence-based recommendations for sequencing strategies.

Main Methods:

• A meta-analysis was performed.
• A cohort of 43 tumors from 13 patients (primaries, regional/distant metastases, recurrences) was sequenced using a 50-gene NGS panel.

Main Results:

• 77% of patient-matched primary-metastatic pairs exhibited identical alterations in the 50 cancer-associated genes analyzed.
• Discordant mutations in TP53, APC, PIK3CA, and SMAD4 were identified and their therapeutic implications discussed.

Conclusions:

• Tumor characteristics (heterogeneity, cellularity) and technical factors (panel size, sample quality) influence mutation detection differences.
• Sequencing additional sites can identify new actionable genomic alterations in patients who fail initial therapy.
• Evidence-based recommendations for sequencing strategies are proposed.